Resveratrol pretreatment attenuates traumatic brain injury in rats by suppressing NLRP3 inflammasome activation via SIRT1

Zou,Peng; Liu,Xiaoxiao; Li,Gang; Wang,Yangang

doi:10.3892/mmr.2017.8241

Resveratrol pretreatment attenuates traumatic brain injury in rats by suppressing NLRP3 inflammasome activation via SIRT1

Authors:
- Peng Zou
- Xiaoxiao Liu
- Gang Li
- Yangang Wang
View Affiliations

Affiliations: Department of Neurosurgery, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China, Department of Cardiology, Xi'an Medical University Affiliated Northern Hospital, Xi'an, Shaanxi 710032, P.R. China, Department of Neurosurgery, Jiangxian People's Hospital, Yuncheng, Shanxi 043600, P.R. China
Published online on: December 11, 2017 https://doi.org/10.3892/mmr.2017.8241
Pages: 3212-3217

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The inflammatory response in the cerebral cortex serves an important role in the progression of secondary injury following traumatic brain injury (TBI). The NLR family pyrin domain containing 3 (NLRP3) inflammasome is necessary for initiating inflammation and is involved in various central nervous system disorders. The aim of the present study was to investigate the neuroprotective effect of resveratrol and elucidate the underlying mechanisms of resveratrol associated regulation of the NLRP3 inflammasome in TBI. The results demonstrated that the activation of NLRP3, caspase‑1 and sirtuin 1 (SIRT1), enhanced the production of inflammatory cytokines and reactive oxygen species (ROS) following TBI. Administration of resveratrol alleviated the degree of TBI, as evidenced by the reduced neuron‑specific enolase (NSE) and brain water content (WBC). Resveratrol pretreatment also inhibited the activation of NLRP3 and caspase‑1, and reduced the production of inflammatory cytokines and ROS. In addition, resveratrol further promoted SIRT1 activation. Furthermore, the suppressing effect of resveratrol on the NLRP3 inflammasome and ROS was blocked by the SIRT1 inhibitor, sirtinol. The results revealed that the activation of the NLRP3 inflammasome and the subsequent inflammatory responses in the cerebral cortex were involved in the process of TBI. Resveratrol may attenuate the inflammatory response and relieve TBI by reducing ROS production and inhibiting NLRP3 activation. The effect of resveratrol on NLRP3 inflammasome and ROS may also be SIRT1 dependent.

View Figures

View References

1	Dong HJ, Shang CZ, Li G, Niu Q, Luo YC, Yang Y, Meng HP, Yin HJ, Zhang HX, Zhao ML and Lin L: The distribution of transplanted umbilical cord mesenchymal stem cells in large blood vessel of rats with traumatic brain injury. J Craniofac Surg. Mar 29–2017.(Epub ahead of print). View Article : Google Scholar
2	Kumar A, Stoica BA, Loane DJ, Yang M, Abulwerdi G, Khan N, Kumar A, Thom SR and Faden AI: Microglial-derived microparticles mediate neuroinflammation after traumatic brain injury. J Neuroinflammation. 14:472017. View Article : Google Scholar : PubMed/NCBI
3	Jin R, Shen M, Yu L, Wang X and Lin X: Adipose-derived stem cells suppress inflammation induced by IL-1β through down-regulation of P2×7R mediated by miR-373 in chondrocytes of osteoarthritis. Mol Cells. 40:222–229. 2017.PubMed/NCBI
4	Song L, Pei L, Yao S, Wu Y and Shang Y: NLRP3 inflammasome in neurological diseases, from functions to therapies. Front Cell Neurosci. 11:632017. View Article : Google Scholar : PubMed/NCBI
5	Minutoli L, Puzzolo D, Rinaldi M, Irrera N, Marini H, Arcoraci V, Bitto A, Crea G, Pisani A, Squadrito F, et al: ROS-mediated NLRP3 inflammasome activation in brain, heart, kidney, and testis ischemia/reperfusion injury. Oxid Med Cell Longev 2016. 21830262016.
6	Tan MS, Yu JT, Jiang T, Zhu XC and Tan L: The NLRP3 inflammasome in Alzheimer's disease. Mol Neurobiol. 48:875–882. 2013. View Article : Google Scholar : PubMed/NCBI
7	Li L and Liu Y: Aging-related gene signature regulated by Nlrp3 predicts glioma progression. Am J Cancer Res. 5:442–449. 2014.PubMed/NCBI
8	Liu HD, Li W, Chen ZR, Hu YC, Zhang DD, Shen W, Zhou ML, Zhu L and Hang CH: Expression of the NLRP3 inflammasome in cerebral cortex after traumatic brain injury in a rat model. Neurochem Res. 38:2072–2083. 2013. View Article : Google Scholar : PubMed/NCBI
9	Jardim FR, de Rossi FT, Nascimento MX, da Silva Barros RG, Borges PA, Prescilio IC and de Oliveira MR: Resveratrol and brain mitochondria: A review. Mol Neurobiol. Mar 10–2017.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
10	Abdel-Aleem GA, Khaleel EF, Mostafa DG and Elberier LK: Neuroprotective effect of resveratrol against brain ischemia reperfusion injury in rats entails reduction of DJ-1 protein expression and activation of PI3K/Akt/GSK3b survival pathway. Arch Physiol Biochem. 122:200–213. 2016. View Article : Google Scholar : PubMed/NCBI
11	Wan D, Zhou Y, Wang K, Hou Y, Hou R and Ye X: Resveratrol provides neuroprotection by inhibiting phosphodiesterases and regulating the cAMP/AMPK/SIRT1 pathway after stroke in rats. Brain Res Bull. 121:255–262. 2016. View Article : Google Scholar : PubMed/NCBI
12	Feng Y, Cui Y, Gao JL, Li MH, Li R, Jiang XH, Tian YX, Wang KJ, Cui CM and Cui JZ: Resveratrol attenuates neuronal autophagy and inflammatory injury by inhibiting the TLR4/NF-κB signaling pathway in experimental traumatic brain injury. Int J Mol Med. 37:921–930. 2016. View Article : Google Scholar : PubMed/NCBI
13	Jiang L, Zhang L, Kang K, Fei D, Gong R, Cao Y, Pan S and Zhao M and Zhao M: Resveratrol ameliorates LPS-induced acute lung injury via NLRP3 inflammasome modulation. Biomed Pharmacother. 84:130–138. 2016. View Article : Google Scholar : PubMed/NCBI
14	Su Q, Pu H and Hu C: Neuroprotection by combination of resveratrol and enriched environment against ischemic brain injury in rats. Neurol Res. 38:60–68. 2016. View Article : Google Scholar : PubMed/NCBI
15	Yang H, Gu ZT, Li L, Maegele M, Zhou BY, Li F, Zhao M and Zhao KS: SIRT1 plays a neuroprotective role in traumatic brain injury in rats via inhibiting the p38 MAPK pathway. Acta Pharmacol Sin. 38:168–181. 2017. View Article : Google Scholar : PubMed/NCBI
16	Wang K, Zhang L, Rao W, Su N, Hui H, Wang L, Peng C, Tu Y, Zhang S and Fei Z: Neuroprotective effects of crocin against traumatic brain injury in mice: Involvement of notch signaling pathway. Neurosci Lett. 591:53–58. 2015. View Article : Google Scholar : PubMed/NCBI
17	Lopez MS, Dempsey RJ and Vemuganti R: Resveratrol neuroprotection in stroke and traumatic CNS injury. Neurochem Int. 89:75–82. 2015. View Article : Google Scholar : PubMed/NCBI
18	Gardner AJ, Shih SL, Adamov EV and Zafonte RD: Research frontiers in traumatic brain injury: Defining the injury. Phys Med Rehabil Clin N Am. 28:413–431. 2017. View Article : Google Scholar : PubMed/NCBI
19	Naghibi T, Mohajeri M and Dobakhti F: Inflammation and outcome in traumatic brain injury: Does gender effect on survival and prognosis? J Clin Diagn Res. 11:PC06–PC09. 2017.PubMed/NCBI
20	Russo MV and McGavern DB: Inflammatory neuroprotection following traumatic brain injury. Science. 353:783–785. 2016. View Article : Google Scholar : PubMed/NCBI
21	Pennisi M, Crupi R, Di Paola R, Ontario ML, Bella R, Calabrese EJ, Crea R, Cuzzocrea S and Calabrese V: Inflammasomes, hormesis, and antioxidants in neuroinflammation: Role of NRLP3 in Alzheimer disease. J Neurosci Res. 95:1360–1372. 2017. View Article : Google Scholar : PubMed/NCBI
22	Wallisch JS, Simon DW, Bayir H, Bell MJ, Kochanek PM and Clark RSB: Cerebrospinal fluid NLRP3 is increased after severe traumatic brain injury in infants and children. Neurocrit Care. 27:44–50. 2017. View Article : Google Scholar : PubMed/NCBI
23	Lin C, Chao H, Li Z, Xu X, Liu Y, Bao Z, Hou L, Liu Y, Wang X, You Y, et al: Omega-3 fatty acids regulate NLRP3 inflammasome activation and prevent behavior deficits after traumatic brain injury. Exp Neurol. 290:115–122. 2017. View Article : Google Scholar : PubMed/NCBI
24	Shah FA, Gim SA, Kim MO and Koh PO: Proteomic identification of proteins differentially expressed in response to resveratrol treatment in middle cerebral artery occlusion stroke model. J Vet Med Sci. 76:1367–1374. 2014. View Article : Google Scholar : PubMed/NCBI
25	Lin CJ, Chen TH, Yang LY and Shih CM: Resveratrol protects astrocytes against traumatic brain injury through inhibiting apoptotic and autophagic cell death. Cell Death Dis. 5:e11472014. View Article : Google Scholar : PubMed/NCBI
26	Gatson JW, Liu MM, Abdelfattah K, Wigginton JG, Smith S, Wolf S and Minei JP: Resveratrol decreases inflammation in the brain of mice with mild traumatic brain injury. J Trauma Acute Care Surg. 74:470–475. 2013. View Article : Google Scholar : PubMed/NCBI
27	Matsushima S and Sadoshima J: The role of sirtuins in cardiac disease. Am J Physiol Heart Circ Physiol. 309:H1375–H1389. 2015. View Article : Google Scholar : PubMed/NCBI
28	Kleszcz R, Paluszczak J and Baer-Dubowska W: Targeting aberrant cancer metabolism-The role of sirtuins. Pharmacol Rep. 67:1068–1080. 2015. View Article : Google Scholar : PubMed/NCBI
29	Tang BL: Sirt1 and the mitochondria. Mol Cells. 39:87–95. 2016. View Article : Google Scholar : PubMed/NCBI
30	Martin A, Tegla CA, Cudrici CD, Kruszewski AM, Azimzadeh P, Boodhoo D, Mekala AP, Rus V and Rus H: Role of SIRT1 in autoimmune demyelination and neurodegeneration. Immunol Res. 61:187–197. 2015. View Article : Google Scholar : PubMed/NCBI
31	Zhao Y, Luo P, Guo Q, Li S, Zhang L, Zhao M, Xu H, Yang Y, Poon W and Fei Z: Interactions between SIRT1 and MAPK/ERK regulate neuronal apoptosis induced by traumatic brain injury in vitro and in vivo. Exp Neurol. 237:489–498. 2012. View Article : Google Scholar : PubMed/NCBI
32	Li Y, Yang X, He Y, Wang W, Zhang J, Zhang W, Jing T, Wang B and Lin R: Negative regulation of NLRP3 inflammasome by SIRT1 in vascular endothelial cells. Immunobiology. 222:552–561. 2017. View Article : Google Scholar : PubMed/NCBI
33	Liu Y, Lian K, Zhang L, Wang R, Yi F, Gao C, Xin C, Zhu D, Li Y, Yan W, et al: TXNIP mediates NLRP3 inflammasome activation in cardiac microvascular endothelial cells as a novel mechanism in myocardial ischemia/reperfusion injury. Basic Res Cardiol. 109:4152014. View Article : Google Scholar : PubMed/NCBI
34	Yin N, Peng Z, Li B, Xia J, Wang Z, Yuan J, Fang L and Lu X: Isoflurane attenuates lipopolysaccharide-induced acute lung injury by inhibiting ROS-mediated NLRP3 inflammasome activation. Am J Transl Res. 8:2033–2046. 2016.PubMed/NCBI
35	Butterfield DA and Reed TT: Lipid peroxidation and tyrosine nitration in traumatic brain injury: Insights into secondary injury from redox proteomics. Proteomics Clin Appl. 10:1191–1204. 2016. View Article : Google Scholar : PubMed/NCBI
36	Rodriguez-Rodriguez A, Egea-Guerrero JJ, Murillo-Cabezas F and Carrillo-Vico A: Oxidative stress in traumatic brain injury. Curr Med Chem. 21:1201–1211. 2014. View Article : Google Scholar : PubMed/NCBI
37	Czerska M, Mikołajewska K, Zieliński M, Gromadzińska J and Wasowicz W: Today's oxidative stress markers. Med Pr. 66:393–405. 2015. View Article : Google Scholar : PubMed/NCBI